October 18, 2017 | City of Hope
City of Hope will be the one of the first authorized centers in the nation to provide axicabtagene ciloleucel, which the U.S. FDA announced today is the first approved CAR-T therapy for adult patients for some types of non-Hodgkin lymphoma
October 23, 2017 | Katie Neith
At City of Hope’s Electron Microscopy Core Facility, researchers can take sharper, closer looks at the structural elements that form the human body at the nanoscale.
July 6, 2017 | Katie Neith
At City of Hope, the Integrative Genomics Core (IGC) provides basic science, translational and clinical researchers with high-quality, efficient, comprehensive and cost-effective genomic services using microarray and high-throughput sequencing technologies.
January 12, 2017 | Katie Neith
A look at the Gene Editing and Viral Vector Core, one of City of Hope’s newest shared resources.